Inspire Veterinary Partners Files 8-K

TL;DR

Inspire Vet Partners filed an 8-K on Jan 10th for Jan 3rd events - changes to rights and bylaws, plus financials.

AI Summary

Inspire Veterinary Partners, Inc. filed an 8-K on January 10, 2025, reporting events as of January 3, 2025. The filing indicates material modifications to the rights of security holders and amendments to its articles of incorporation or bylaws. It also includes financial statements and exhibits.

Why It Matters

This 8-K filing signals potential changes in the company's structure or security holder rights, which could impact investors.

Risk Assessment

Risk Level: medium — Filings related to modifications of security holder rights and amendments to bylaws can indicate significant corporate changes that may affect stock value.

Key Players & Entities

• INSPIRE VETERINARY PARTNERS, INC. (company) — Registrant
• January 3, 2025 (date) — Earliest event reported
• January 10, 2025 (date) — Date of report
• Nevada (jurisdiction) — State of incorporation
• 780 Lynnhaven Parkway , Suite 400 Virginia Beach , VA 23452 (address) — Principal executive offices

FAQ

Key Financial Figures

• $0.0001 — ch registered Common stock, par value $0.0001 IVP Nasdaq Capital Market Indicat
• $1.00 — ice of the Company's Common Stock above $1.00 per share and bring the Company back in

Filing Documents

• ea0227311-8k_inspire.htm (8-K) — 32KB
• ea022731101ex3-1_inspire.htm (EX-3.1) — 1KB
• ex3-1_001.jpg (GRAPHIC) — 494KB
• 0001213900-25-002265.txt ( ) — 887KB
• ivp-20250103.xsd (EX-101.SCH) — 3KB
• ivp-20250103_lab.xml (EX-101.LAB) — 33KB
• ivp-20250103_pre.xml (EX-101.PRE) — 22KB
• ea0227311-8k_inspire_htm.xml (XML) — 4KB

03 Material

Item 3.03 Material Modification to Rights of Security Holders. As previously disclosed in a Schedule 14C, on November 15, 2024, the majority stockholders of Inspire Veterinary Partners, Inc., a Nevada corporation (the "Company") approved, by written consent in lieu of a special meeting, the granting of the authority to our board of directors (the "Board") to amend the Company's Amended and Restated Articles of Incorporation to effect a reverse stock split of the issued and outstanding shares of the Company's Class A common stock (the "Common Stock"), by a ratio of not less than 1-for-2 and not more than 1-for-50, with the exact ratio to be determined by the Board in its sole discretion. On January 3, 2025 the Board determined, after reviewing the number of currently issued and outstanding shares of the Company, that it is in the best interests of the Company to effectuate a reverse stock split at a ratio of one-for-twenty-five (1:25) (the "Reverse Stock Split"). The Company is effectuating the Reverse Stock Split in order to raise the per share bid price of the Company's Common Stock above $1.00 per share and bring the Company back into compliance with Nasdaq Listing Rule 5550(a)(2). The Company will have regained compliance once the Company's Common Stock trades at or above $1.00 per share for a minimum of 10 consecutive trading days, at which time Nasdaq will provide the Company with notice that it has regained compliance.

03 Amendment

Item 5.03 Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year On January 3, 2025, the Company filed a Certificate of Change to the Company's Amended and Restated Certificate of Incorporation, as previously amended, with the Secretary of State of the State of Nevada to effect the Reverse Stock Split. Every twenty-five (25) shares of the Common Stock issued and outstanding or held as treasury stock will be automatically reclassified into one (1) new share of Common Stock. The total number of shares of Common Stock authorized for issuance will then be reduced by a corresponding proportion from 100,000,000 shares to 4,000,000 shares. A copy of the Certificate of Change is attached hereto as Exhibit 3.1 and incorporated herein by reference. The description of the Certificate of Change and the Reverse Stock Split set forth in Item 3.03 of this Current Report are incorporated herein by reference. Except for de minimis adjustments that result from the treatment of fractional shares, the Reverse Stock Split does not have any immediate dilutive effect on our stockholders, since each stockholder holds the same percentage of our Common Stock outstanding immediately following the Reverse Stock Split as such stockholder held immediately prior to the Reverse Stock Split. As a result of the Reverse Stock Split, the number of shares of the Company's Common Stock that may be purchased upon the exercise of outstanding warrants, options, or other securities convertible into, or exercisable or exchangeable for, shares of our Common Stock, and the exercise or conversion prices for these securities, have also be ratably adjusted in accordance with their terms and conditions. Item 9.01 Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Description 3.1 Certificate of Change to the Company's Amended and Restated Certificate of Incorporation of Inspire Veterinary Partners, Inc., filed January 3, 2025 104 Cover Page Interactive Data File (embed

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 10, 2025 INSPIRE VETERINARY PARTNERS, INC. By: /s/ Kimball Carr Name: Kimball Carr Title: President and Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR